참고문헌
- Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. PT. 2015;40:277-283.
- Sengupta S, Chattopadhyay MK, Grossart HP. The multifaceted roles of antibiotics and antibiotic resistance in nature. Front Microbiol. 2013;4:47. https://doi.org/10.3389/fmicb.2013.00047
- Centers for Disease Control and Prevention. Office of infectious disease antibiotic resistance threats in the United States, 2013 [Internet]. Atlanta: Centers for Disease Control and Prevention; 2015 [cited 2019 August 28]. Available from: https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
- Kim JE. Carbapenem-resistant Enterobacteriaceae in Korea. Hanyang Med Rev. 2018;38:99-102. https://doi.org/10.7599/hmr.2018.38.2.99
- Centers for Disease Control and Prevention. FAQs about choosing and implementing a CRE definition [Internet]. Atlanta: Centers for Disease Control and Prevention; 2015 [cited 2019 August 28]. Available from: https://www.cdc.gov/hai/organisms/cre/definition.html.
- Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18:318-327. https://doi.org/10.1016/S1473-3099(17)30753-3
- McCann E, Srinivasan A, DeRyke CA, DePestel DD, Murray J, Gupta V. Carbapenem-nonsusceptible gram-negative pathogens in ICU and non-ICU settings in US hospitals in 2017: a multicenter study. Open Forum Infect Dis. 2018;5:ofy241. https://doi.org/10.1093/ofid/ofy241
- Potter RF, D'Souza AW, Dantas G. The rapid spread of carbapenem-resistant Enterobacteriaceae. Drug Resist Updat. 2016;29:30-46. https://doi.org/10.1016/j.drup.2016.09.002
- Iovleva A, Doi Y. Carbapenem-resistant Enterobacteriaceae. Clin Lab Med. 2017;37:303-315. https://doi.org/10.1016/j.cll.2017.01.005
- Lee HJ, Lee DG. Carbapenem-resistant Enterobacteriaceae: recent updates and treatment strategies. J Korean Med Assoc. 2018;61:281-289. https://doi.org/10.5124/jkma.2018.61.4.281
- Tamma PD, Goodman KE, Harris AD, Tekle T, Roberts A, Taiwo A, et al. Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase producing carbapenem- resistant Enterobacteriaceae bacteremia. Clin Infect Dis. 2017;64:257-264. https://doi.org/10.1093/cid/ciw741
- Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis. 2014;20:1170-1175. https://doi.org/10.3201/eid2007.121004
- Hauck C, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, et al. Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections. Clin Microbiol Infect. 2016;22:513-519. https://doi.org/10.1016/j.cmi.2016.01.023
- Goodman KE, Simner PJ, Tamma PD, Milstone AM. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE). Expert Rev Anti Infect Ther. 2016;14:95-108. https://doi.org/10.1586/14787210.2016.1106940
- Aires-de-Sousa M, Ortiz de la Rosa JM, Goncalves ML, Pereira AL, Nordmann P, Poirel L. Epidemiology of carbapenemase-producing Klebsiella pneumoniae in a hospital, Portugal. Emerg Infect Dis. 2019;25:1632-1638. https://doi.org/10.3201/eid2509.190656
- van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017;8:460-469. https://doi.org/10.1080/21505594.2016.1222343
- Korea Centers for Disease Control and Prevention. 2017 Guidelines for management of medical-related infectious diseases (VRSA/CRE) [Internet]. Cheongju: Korea Centers for Disease Control and Prevention; 2017 [cited 2019 August 28]. Available from: http://www.cdc.go.kr/board.es?mid=a20507020000&bid=0019&act=view&list_no=138074.
- Jeong SH, Kim HS, Kim JS, Shin DH, Kim HS, Park MJ, et al. Prevalence and molecular characteristics of carbapenemase-producing Enterobacteriaceae from five hospitals in Korea. Ann Lab Med. 2016;36:529-535. https://doi.org/10.3343/alm.2016.36.6.529
- Ahn SY, Sung JY, Kim HS, Kim MS, Hwang YJ, Jong SR, et al. Molecular epidemiology and characterization of carbapenemase-producing Enterobacteriaceae isolated at a university hospital in Korea during 4-year period. Ann Clin Microbiol. 2016;19:39-47. https://doi.org/10.5145/ACM.2016.19.2.39
- Lodise TP, Bonine NG, Ye JM, Folse HJ, Gillard P. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections. BMC Infectious Diseases. 2019;19:718. https://doi.org/10.1186/s12879-019-4363-y
- Gupta V, Ye G, Olesky M, Lawrence K, Murray J, Yu K. Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013-2017. BMC Infect Dis. 2019;19:742. https://doi.org/10.1186/s12879-019-4387-3
- Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement M100-S27. Wayne, PA: Clinical Laboratory Standards Institute; 2017.
- Bonomo RA, Burd EM, Conly J, Limbago BM, Poirel L, Segre JA, et al. Carbapenemase-producing organisms: a global scourge. Clin Infect Dis. 2018;66:1290-1297. https://doi.org/10.1093/cid/cix893
- Bora A, Sanjana R, Jha BK, Mahaseth SN, Pokharel K. Incidence of metallo-beta-lactamase producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in central Nepal. BMC Res Notes. 2014;7:557. https://doi.org/10.1186/1756-0500-7-557
- Monteiro J, Widen RH, Pignatari ACC, Kubasek C, Silbert S. Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother. 2012;67:906-909. https://doi.org/10.1093/jac/dkr563
- Doyle D, Peirano G, Lascols C, Lloyd T, Church DL, Pitout JD. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol. 2012;50:3877-3880. https://doi.org/10.1128/JCM.02117-12
- Rhee JY, Park YK, Shin JY, Choi JY, Lee MY, Peck KR, et al. KPC producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea. Antimicrob Agents Chemother. 2010;54:2278-2279. https://doi.org/10.1128/AAC.00011-10
- Bae IK, Kang HK, Jang IH, Lee W, Kim K, Kim JO, et al. Detection of carbapenemases in clinical Enterobacteriaceae isolates using the VITEK AST-N202 card. Infect Chemother. 2015;47:167-174. https://doi.org/10.3947/ic.2015.47.3.167
- Roh KH, Lee CK, Sohn JW, Song W, Yong D, Lee K. Isolation of a Klebsiella pneumoniae isolate of sequence type 258 producing KPC-2 carbapenemase in Korea. Korean J Lab Med. 2011;31:298-301. https://doi.org/10.3343/kjlm.2011.31.4.298
- Jeong SH, Lee KM, Lee J, Bae IK, Kim JS, Kim HS, et al. Clonal and horizontal spread of the bla OXA-232 gene among Enterobacteriaceae in a Korean hospital. Diagn Microbiol Infect Dis. 2015;82:70-72. https://doi.org/10.1016/j.diagmicrobio.2015.02.001
- Garg A, Garg J, Kumar S, Bhattacharya A, Agarwal S, Upadhyay GC. Molecular epidemiology & therapeutic options of carbapenem-resistant gram-negative bacteria. Indian J Med Res. 2019;149:285-289. https://doi.org/10.4103/ijmr.IJMR_36_18
- Centers for Disease Control and Prevention. Patients with NDM-producing carbapenem-resistant Enterobacteriaceae (CRE) reported to the Centers for Disease Control and Prevention (CDC) as of December 2017, by state [Internet]. Atlanta: Centers for Disease Control and Prevention; 2017 [cited 2019August 28]. Available from: https://www.cdc.gov/hai/organisms/cre/trackingcre.html.
- Rodriguez-Bano J, Gutierrez-Gutierrez B, Machuca I, Pascual A. Treatment of infections caused by extended-spectrum- beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae. Clin Microbiol Rev. 2018;31:1-42. https://doi.org/10.1128/CMR.00079-17
- Park JW, Lee EJ, et al. Status of carbapenemase producing Enterobacteriaceae incidences in Korea, 2015-2016. Research report. Cheongju: Korea Centers for Disease Control and Prevention; 2017;10:1243-1247.
- Go EB, Ju SJ, et al. Distribution of carbapenem-resistant Enterobacteriaceae (CRE) in Korea, 2017. Research report. Cheongju: Korea Centers for Disease Control and Prevention; 2018;11:1518-1522.
- Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol. 2016;37:1288-1301. https://doi.org/ 10.1017/ice.2016.174